About this FactMed analysis covering adverse side effect reports of RENIVACE patients who developed ADHESION.

FactMed provides MD-approved analysis to help both patients, researchers, and physicians accurately assess the risk profile for more than 20,000 different pharmaceutical products. The below report offers compiled information from Food & Drug Administration and FactMed user submissions. Between January 2004 and October 2012, 1 individuals taking RENIVACE reported ADHESION to the FDA. A total of 1237 RENIVACE drug adverse event reaction reports were made with the FDA during this time period. Often the FDA only receives reports of the most critical and severe cases; these numbers may therefore underrepresent the complication rate of the medication.

FDA Research Report

Introduction This page is designed to help you determine the relationship, if any, between RENIVACE and ADHESION. In doing so, we compare RENIVACE with other drugs that cause ADHESION, to help you evaluate whether or not RENIVACE causes ADHESION. Likewise, this page shows the most highly-reported side effects of RENIVACE, so you can see if ADHESION ranks among RENIVACE's most well-known side effects.
Summary Statistics
Reports of RENIVACE causing ADHESION: 1
Reports of any side effect of RENIVACE : 1237
Percentage of RENIVACE patients where ADHESION is a reported side effect: 0.0808%

FDA reports of any drug causing ADHESION : 955
Average percentage for all medicated patients where ADHESION is reported as a complication: 0.0060%

Physician opinion on RENIVACE as adverse event culprit:

Overall opinion for all reports of this drug:
Most frequent diagnoses/indications for prescribing RENIVACE:
HYPERTENSION ( 436 patients )
CARDIAC FAILURE ( 52 patients )
DRUG USE FOR UNKNOWN INDICATION ( 30 patients )
CARDIAC FAILURE CHRONIC ( 14 patients )
MYOCARDIAL INFARCTION ( 11 patients )
CARDIAC FAILURE CONGESTIVE ( 11 patients )
PROPHYLAXIS ( 8 patients )
ESSENTIAL HYPERTENSION ( 6 patients )
GLOMERULONEPHRITIS MEMBRANOUS ( 5 patients )
RENAL DISORDER ( 4 patients )
ACUTE MYOCARDIAL INFARCTION ( 4 patients )
PRODUCT USED FOR UNKNOWN INDICATION ( 4 patients )
PULMONARY ARTERIAL HYPERTENSION ( 4 patients )
ANGINA PECTORIS ( 3 patients )
RENAL HYPERTENSION ( 3 patients )
CARDIOPLEGIA ( 2 patients )
UNIVENTRICULAR HEART ( 2 patients )
ATRIAL FIBRILLATION ( 2 patients )
LUPUS NEPHRITIS ( 2 patients )
NEPHROTIC SYNDROME ( 2 patients )
CARDIAC DISORDER ( 2 patients )
CONGESTIVE CARDIOMYOPATHY ( 2 patients )
AORTIC VALVE REPLACEMENT ( 2 patients )
BLOOD PRESSURE INCREASED ( 2 patients )
HYPOKALAEMIA ( 1 patients )
BLOOD PRESSURE DECREASED ( 1 patients )
PULMONARY HYPERTENSION ( 1 patients )
CARDIOMYOPATHY ( 1 patients )
ILL-DEFINED DISORDER ( 1 patients )
BLOOD PRESSURE ( 1 patients )
( 0 patients )
Drugs with high FDA adverse event association with ADHESION:

FOSAMAX (219 patients)
VIOXX (200 patients)
HUMIRA (129 patients)
REMICADE (102 patients)
PEGASYS (82 patients)
ACCUTANE (70 patients)
LIPITOR (58 patients)
NEURONTIN (55 patients)
ASPIRIN (46 patients)
AVONEX (45 patients)
SYNTHROID (44 patients)
PRILOSEC (42 patients)
LORAZEPAM (41 patients)
COPEGUS (40 patients)
FOLIC ACID (40 patients)
VITAMIN E (39 patients)
PAXIL (38 patients)
METHOTREXATE (37 patients)
CELEBREX (37 patients)
DIANEAL (37 patients)
PREMARIN (37 patients)
LISINOPRIL (32 patients)
HYDROCHLOROTHIAZIDE (31 patients)
LYRICA (30 patients)
FLOVENT (30 patients)
XANAX (28 patients)
LIORESAL (28 patients)
NORVASC (27 patients)
PREDNISONE (27 patients)
IBUPROFEN (27 patients)
ACTONEL (26 patients)
ALBUTEROL (26 patients)
[THERAPY UNSPECIFIED] (26 patients)
CALCIUM (UNSPECIFIED) (26 patients)
DIGOXIN (25 patients)
AMBIEN (25 patients)
PROTONIX (25 patients)
FUROSEMIDE (24 patients)
ATENOLOL (24 patients)
LASIX (23 patients)
OXYCONTIN (23 patients)
NEXIUM (23 patients)
FLEXERIL (22 patients)
ACETAMINOPHEN (21 patients)
FOSAMAX PLUS D (21 patients)
ZANTAC (21 patients)
ZOLOFT (21 patients)
EVISTA (21 patients)
VITAMIN D (21 patients)
CIPRO (20 patients)
LEVOTHYROXINE SODIUM (20 patients)
FORTEO (19 patients)
PREDNISONE TAB (19 patients)
LANOXIN (19 patients)
LEXAPRO (18 patients)
ACIPHEX (18 patients)
LORTAB (18 patients)
COUMADIN (18 patients)
OMEPRAZOLE (18 patients)
FLUOROURACIL (18 patients)
VERAPAMIL (17 patients)
VITAMINS (UNSPECIFIED) (17 patients)
PERCOCET (17 patients)
HYDROCODONE BITARTRATE (17 patients)
TRAZODONE HYDROCHLORIDE (17 patients)
CLARITIN (17 patients)
CLONAZEPAM (17 patients)
MULTI-VITAMIN (17 patients)
MYCOPHENOLATE MOFETIL (16 patients)
DETROL LA (16 patients)
ACETAMINOPHEN AND HYDROCODONE BITARTRATE (16 patients)
SEROQUEL (16 patients)
AMITRIPTYLINE HYDROCHLORIDE (16 patients)
AMPICILLIN (16 patients)
ZOFRAN (16 patients)
VALIUM (15 patients)
CYANOCOBALAMIN (14 patients)
ALPRAZOLAM (14 patients)
WARFARIN SODIUM (14 patients)
VICODIN (14 patients)
ACYCLOVIR (13 patients)
LEVAQUIN (13 patients)
ROBAXIN (13 patients)
ALENDRONATE SODIUM (13 patients)
DECADRON (13 patients)
MORPHINE (13 patients)
VITAMIN B-12 (13 patients)
BACTRIM DS (13 patients)
ZELNORM (13 patients)
CIMZIA (13 patients)
ENTOCORT EC (13 patients)
ALTACE (12 patients)
VENTOLIN (12 patients)
K-DUR 10 (12 patients)
LEUCOVORIN CALCIUM (12 patients)
CYMBALTA (12 patients)
DEXAMETHASONE (12 patients)
MIRENA (12 patients)
GOLIMUMAB (12 patients)
HORMONES (UNSPECIFIED) (12 patients)
PREVACID (12 patients)
PRIMIDONE (12 patients)
CITALOPRAM HYDROBROMIDE (12 patients)
FENTANYL (12 patients)
VYTORIN (12 patients)
VITAMIN D (UNSPECIFIED) (11 patients)
ZOCOR (11 patients)
PREDNISOLONE (11 patients)
DOXORUBICIN HCL (11 patients)
POTASSIUM CHLORIDE (11 patients)
OYST CAL D (11 patients)
FAMOTIDINE (11 patients)
REGLAN (11 patients)
WELLBUTRIN (11 patients)
GABAPENTIN (11 patients)
OXYCODONE HCL (11 patients)
ZETIA (11 patients)
DULCOLAX (11 patients)
URBASON (11 patients)
CLOZARIL (11 patients)
CLONIDINE (11 patients)
RANITIDINE (11 patients)
REBIF (10 patients)
PREMPRO (10 patients)
YAZ (10 patients)
CLONOPIN (10 patients)
ESTRATEST (10 patients)
VITAMINS (10 patients)
ASCORBIC ACID (10 patients)
TOCILIZUMAB (10 patients)
DEPAKOTE (10 patients)
MIACALCIN (10 patients)
DOSTINEX (10 patients)
BACLOFEN (10 patients)
CELEXA (10 patients)
NITROSTAT (10 patients)
LANTUS (10 patients)
CALCIUM (10 patients)
DIFLUCAN (9 patients)
ENBREL (9 patients)
ONDANSETRON (9 patients)
TEGRETOL (9 patients)
PROMETHAZINE (9 patients)
INDAPAMIDE (9 patients)
ADVAIR DISKUS 100/50 (9 patients)
PLAVIX (9 patients)
LANSOPRAZOLE (9 patients)
TACROLIMUS (9 patients)
AMOXICILLIN (9 patients)
IMURAN (9 patients)
MULTI-VITAMINS (9 patients)
DIOVAN (9 patients)
MORPHINE SULFATE (9 patients)
CENTRUM (9 patients)
BIRTH CONTROL PILLS (9 patients)
ESTRADIOL (9 patients)
CALCIUM GLUCONATE (9 patients)
LUPRON DEPOT (9 patients)
FISH OIL (9 patients)
DICLOFENAC (9 patients)
CALCIUM CARBONATE (9 patients)
LOVENOX (8 patients)
MIRALAX (8 patients)
SALAGEN (8 patients)
CELECOXIB (8 patients)
ULTRAM (8 patients)
DEPO-PROVERA (8 patients)
TRAZODONE HCL (8 patients)
SK-ERYTHROMYCIN (8 patients)
MIRAPEX (8 patients)
VALTREX (8 patients)
TYLENOL (CAPLET) (8 patients)
YASMIN (8 patients)
RENAGEL (8 patients)
SERTRALINE HYDROCHLORIDE (8 patients)
CRESTOR (8 patients)
CARTICEL (8 patients)
AUGMENTIN '125' (8 patients)
DICLOFENAC SODIUM (8 patients)
AVASTIN (8 patients)
PENTASA (8 patients)
VELCADE (8 patients)
VANCOMYCIN (8 patients)
VINCRISTINE (8 patients)
PROGRAF (8 patients)
FLAGYL (8 patients)
UNCODEABLE ^UNCLASSIFIABLE^ (7 patients)
ELIDEL (7 patients)
FLOXIN OTIC (7 patients)
ACTOS (7 patients)
CLINDAMYCIN (7 patients)
IMIPRAMINE (7 patients)
OXALIPLATIN (7 patients)
AMITRIPTYLINE HCL (7 patients)
CIPROFLOXACIN (7 patients)
NIFEDIPINE (7 patients)
LAMICTAL (7 patients)
COZAAR (7 patients)
WARFARIN (7 patients)
FLORINEF (7 patients)
METOPROLOL (7 patients)
HUMALOG (7 patients)
BEVACIZUMAB (7 patients)
ISONIAZID (7 patients)
KLONOPIN (7 patients)
PROZAC (7 patients)
CALCICHEW (7 patients)
PYRIDIUM (7 patients)
RAMIPRIL (7 patients)
NUVARING (7 patients)
Most common side effects for patients taking RENIVACE:
PYREXIA (95 patients)
CARDIAC FAILURE (79 patients)
PLATELET COUNT DECREASED (76 patients)
INTERSTITIAL LUNG DISEASE (76 patients)
ANAEMIA (66 patients)
BLOOD LACTATE DEHYDROGENASE INCREASED (64 patients)
BLOOD CREATININE INCREASED (62 patients)
BLOOD ALKALINE PHOSPHATASE INCREASED (55 patients)
BRADYCARDIA (54 patients)
ASPARTATE AMINOTRANSFERASE INCREASED (53 patients)
HEPATIC FUNCTION ABNORMAL (53 patients)
RENAL FAILURE ACUTE (48 patients)
MALAISE (47 patients)
PNEUMONIA (47 patients)
GAMMA-GLUTAMYLTRANSFERASE INCREASED (45 patients)
HAEMOGLOBIN DECREASED (45 patients)
ALANINE AMINOTRANSFERASE INCREASED (43 patients)
CONDITION AGGRAVATED (41 patients)
BLOOD UREA INCREASED (40 patients)
VOMITING (39 patients)
NAUSEA (38 patients)
DEPRESSED LEVEL OF CONSCIOUSNESS (38 patients)
DECREASED APPETITE (38 patients)
BLOOD PRESSURE DECREASED (37 patients)
WHITE BLOOD CELL COUNT DECREASED (37 patients)
ANOREXIA (35 patients)
HYPERKALAEMIA (35 patients)
DRUG INTERACTION (35 patients)
C-REACTIVE PROTEIN INCREASED (35 patients)
HYPOGLYCAEMIA (33 patients)
LOSS OF CONSCIOUSNESS (32 patients)
WHITE BLOOD CELL COUNT INCREASED (32 patients)
LIVER DISORDER (32 patients)
RENAL IMPAIRMENT (30 patients)
HAEMATOCRIT DECREASED (28 patients)
BLOOD CREATINE PHOSPHOKINASE INCREASED (28 patients)
DYSPNOEA (28 patients)
THROMBOCYTOPENIA (27 patients)
RHABDOMYOLYSIS (27 patients)
SEPSIS (26 patients)
RESPIRATORY FAILURE (26 patients)
BLOOD GLUCOSE INCREASED (26 patients)
SHOCK (24 patients)
HYPERTENSION (24 patients)
RED BLOOD CELL COUNT DECREASED (24 patients)
RASH (24 patients)
HYPOTENSION (23 patients)
OEDEMA (23 patients)
HALLUCINATION (23 patients)
DIALYSIS (23 patients)
DIARRHOEA (22 patients)
NEUTROPHIL COUNT DECREASED (21 patients)
CEREBRAL INFARCTION (21 patients)
EOSINOPHIL COUNT INCREASED (20 patients)
AGRANULOCYTOSIS (20 patients)
DIZZINESS (20 patients)
COUGH (20 patients)
STEVENS-JOHNSON SYNDROME (20 patients)
CONVULSION (20 patients)
WEIGHT INCREASED (20 patients)
DEHYDRATION (20 patients)
CEREBRAL HAEMORRHAGE (20 patients)
PLEURAL EFFUSION (19 patients)
ACUTE RESPIRATORY DISTRESS SYNDROME (19 patients)
STOMATITIS (19 patients)
RENAL FAILURE (19 patients)
BLOOD POTASSIUM INCREASED (19 patients)
BLOOD SODIUM DECREASED (19 patients)
HYPONATRAEMIA (18 patients)
PROTEIN URINE PRESENT (18 patients)
PANCYTOPENIA (18 patients)
BLOOD PRESSURE SYSTOLIC INCREASED (18 patients)
INAPPROPRIATE ANTIDIURETIC HORMONE SECRETION (18 patients)
DELIRIUM (18 patients)
BLOOD BILIRUBIN INCREASED (17 patients)
BLOOD CHLORIDE DECREASED (17 patients)
BLOOD PRESSURE INCREASED (17 patients)
OEDEMA PERIPHERAL (17 patients)
LYMPHOCYTE STIMULATION TEST POSITIVE (16 patients)
ACUTE MYOCARDIAL INFARCTION (16 patients)
ANGIONEUROTIC OEDEMA (16 patients)
BLOOD URIC ACID INCREASED (16 patients)
GAIT DISTURBANCE (16 patients)
CARDIO-RESPIRATORY ARREST (16 patients)
ERYTHEMA (16 patients)
ALTERED STATE OF CONSCIOUSNESS (15 patients)
DISSEMINATED INTRAVASCULAR COAGULATION (15 patients)
ASTHENIA (15 patients)
HAEMODIALYSIS (15 patients)
DYSSTASIA (14 patients)
DIABETES MELLITUS (14 patients)
FALL (14 patients)
PALMAR-PLANTAR ERYTHRODYSAESTHESIA SYNDROME (14 patients)
SOMNOLENCE (14 patients)
HYPERLIPIDAEMIA (14 patients)
HYPERGLYCAEMIA (14 patients)
TREMOR (14 patients)
ATRIAL FIBRILLATION (14 patients)
JAUNDICE (14 patients)
LYMPHOCYTE COUNT DECREASED (14 patients)
CARDIAC FAILURE CHRONIC (14 patients)
LEUKOPENIA (13 patients)
GASTROINTESTINAL HAEMORRHAGE (13 patients)
HYPERURICAEMIA (13 patients)
ENTEROCOLITIS (13 patients)
PROTEIN TOTAL DECREASED (13 patients)
CONSTIPATION (13 patients)
PRURITUS (13 patients)
MYOCARDIAL INFARCTION (13 patients)
CARDIAC ARREST (13 patients)
DELUSION (13 patients)
SYNCOPE (12 patients)
URINARY TRACT INFECTION (12 patients)
PAIN (12 patients)
FACE OEDEMA (12 patients)
SUDDEN DEATH (12 patients)
IDIOPATHIC THROMBOCYTOPENIC PURPURA (12 patients)
PULMONARY INFARCTION (11 patients)
TACHYCARDIA (11 patients)
RENAL DISORDER (11 patients)
HEADACHE (11 patients)
UPPER RESPIRATORY TRACT INFLAMMATION (11 patients)
SWELLING (11 patients)
DEATH (11 patients)
NEUTROPHIL COUNT INCREASED (11 patients)
ILEUS PARALYTIC (11 patients)
CONTUSION (11 patients)
ABDOMINAL PAIN (10 patients)
GASTRIC ULCER (10 patients)
MUSCULAR WEAKNESS (10 patients)
HAEMORRHAGE SUBCUTANEOUS (10 patients)
BLOOD ALBUMIN DECREASED (10 patients)
BLOOD IMMUNOGLOBULIN E INCREASED (10 patients)
BLOOD IMMUNOGLOBULIN G INCREASED (10 patients)
COLONIC POLYP (10 patients)
BLOOD PRESSURE DIASTOLIC DECREASED (10 patients)
PSYCHIATRIC SYMPTOM (10 patients)
CARDIAC FAILURE CONGESTIVE (10 patients)
ABDOMINAL PAIN UPPER (9 patients)
DISEASE PROGRESSION (9 patients)
MONOCYTE COUNT DECREASED (9 patients)
HYPERCHOLESTEROLAEMIA (9 patients)
AGITATION (9 patients)
FIBRIN DEGRADATION PRODUCTS INCREASED (9 patients)
DRUG LEVEL INCREASED (9 patients)
NASOPHARYNGITIS (9 patients)
CHILLS (9 patients)
ARRHYTHMIA (9 patients)
FRACTURE (9 patients)
BACK PAIN (9 patients)
BACTERIAL INFECTION (9 patients)
DEPRESSION (9 patients)
DISCOMFORT (9 patients)
SUICIDE ATTEMPT (9 patients)
SUBCUTANEOUS ABSCESS (9 patients)
STAPHYLOCOCCAL SEPSIS (9 patients)
GASTRIC CANCER (9 patients)
PLATELET COUNT INCREASED (9 patients)
PNEUMONIA ASPIRATION (9 patients)
DRUG ERUPTION (9 patients)
BLOOD PRESSURE INADEQUATELY CONTROLLED (9 patients)
HYPOKALAEMIA (9 patients)
OSTEOPENIA (9 patients)
CONCOMITANT DISEASE AGGRAVATED (8 patients)
SINUS ARREST (8 patients)
CONFUSIONAL STATE (8 patients)
IMMUNOSUPPRESSANT DRUG LEVEL INCREASED (8 patients)
ANURIA (8 patients)
HEPATIC NEOPLASM MALIGNANT (8 patients)
AORTIC CALCIFICATION (8 patients)
DIVERTICULITIS (8 patients)
THROMBOSIS IN DEVICE (8 patients)
ASCITES (8 patients)
TOXIC EPIDERMAL NECROLYSIS (8 patients)
ATRIOVENTRICULAR BLOCK (8 patients)
DYSPHAGIA (8 patients)
INSOMNIA (8 patients)
WEIGHT DECREASED (8 patients)
BILOMA (8 patients)
DISEASE RECURRENCE (8 patients)
LYMPH NODE TUBERCULOSIS (8 patients)
CHEST PAIN (8 patients)
MOUTH ULCERATION (8 patients)
GENERAL PHYSICAL HEALTH DETERIORATION (8 patients)
GENERALISED ERYTHEMA (8 patients)
PURULENT DISCHARGE (8 patients)
NEUTROPHIL PERCENTAGE INCREASED (8 patients)
HAEMOPTYSIS (8 patients)
OESOPHAGEAL NEOPLASM (8 patients)
EOSINOPHIL COUNT DECREASED (8 patients)
DEMENTIA (8 patients)
OESOPHAGEAL ULCER (8 patients)
CARDIOMEGALY (8 patients)
LUNG DISORDER (7 patients)
SPEECH DISORDER (7 patients)
EOSINOPHILIA (7 patients)
LARYNGEAL OEDEMA (7 patients)
EATING DISORDER (7 patients)
OVERDOSE (7 patients)
PALPITATIONS (7 patients)
PAIN IN EXTREMITY (7 patients)
PULMONARY HAEMORRHAGE (7 patients)
EOSINOPHIL PERCENTAGE DECREASED (7 patients)
HAEMORRHAGE (7 patients)
DIABETES MELLITUS INADEQUATE CONTROL (7 patients)
STREPTOCOCCAL INFECTION (7 patients)
SCHIZOPHRENIA (7 patients)
HEART RATE DECREASED (7 patients)
CELLULITIS (7 patients)
HEART RATE INCREASED (7 patients)

In addition to reviewing our up-to-date FDA research, users may interact with the FactMed community - currently one million members and growing! FactMed online research and discussions are read by patients, scientists, physicians, and other interested health care parties. Post follow up Questions to learn from our diverse readership. Likewise, patients who have experienced unwanted effects are encouraged to share their Concerns to help educate and inform our members.


Recent FactMed Activity for RENIVACE


Issue Description / Topic Timestamp

My Patient Resources

Get your questions answered! Over one million patients, researchers, and health care providers have visited FactMed. If you have a question about ADHESION and RENIVACE, post it here. You may receive a response from a fellow patient - or a leading expert in the field.
Your Question:

Share your experience: Over one million patients, researchers, and health care providers have visited FactMed. If you have a noteworthy experience as a patient taking RENIVACE, post it here. Your story could help a fellow patient - or provide insight to a leading expert in the field.
Your Experience or Concern:

Telemedicine Expert Consults FactMed newest feature allows patients to consult - via realtime videoconferencing - experts in RENIVACE. This premium feature connects patients to experts, regardless of geography. FactMed experts charge reasonable rates that may be reimbursable by your insurance as a second-opinion.
We are currently accepting registration for RENIVACE experts. If you are a healthcare provider experienced in prescribing RENIVACE, please register here.

Your online appointment book for Medway Rentals & Services



© 2014 FactMed, Inc
Privacy Policy
Terms of Use